Related Experiment Videos
Prednisolone acetate-gentamicin combination following cataract surgery
Annals of Ophthalmology
|July 1, 1987
Summary
This study found that a prednisolone acetate-gentamicin ophthalmic suspension effectively controlled inflammation and prevented infection after cataract surgery over 21 days. The combination therapy demonstrated safety and positive therapeutic effects in patients.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Cataract surgery can lead to postoperative inflammation and infection.
- Effective management of these complications is crucial for visual recovery.
Purpose of the Study:
- To evaluate the therapeutic efficacy and safety of prednisolone acetate 1%-gentamicin 0.3% ophthalmic suspension.
- To assess the drug's ability to control inflammation and prevent infection post-cataract surgery.
Main Methods:
- A 21-day, open-label study involving 111 patients.
- Medication (prednisolone acetate-gentamicin) instilled four times daily starting the day after surgery.
Main Results:
- No postoperative infections were observed in any participants.
- Mild postoperative inflammation noted immediately after surgery decreased steadily.
- The treatment regimen was well-tolerated, indicating good safety.
Conclusions:
- Prednisolone acetate-gentamicin ophthalmic suspension is safe and effective for controlling postoperative inflammation.
- This combination therapy successfully prevents infection following cataract surgery.
- A three-week treatment course shows positive therapeutic outcomes.